Overview

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

Principal investigator

Antonio Sanchez
Internal Medicine

Eligibility criteria

Inclusion Criteria:
*  Provide signed informed consent at the screening visit as well as comply with all study visits and requirements through the end of the study
*  Male or female, age ≥18 years at the screening visit
*  Confirmed diagnosis of PBC in line with the AASLD guidelines
*  UDCA and anti-pruritic medication use will be allowed if meeting additional criteria
*  Qualified pruritus associated with PBC as assessed by Adult ItchRO

Exclusion Criteria:
*  Pruritus associated with an etiology other than PBC
*  Evidence or clinical suspicion of decompensated cirrhosis or a history of decompensation events
*  Current symptomatic cholelithiasis or inflammatory gallbladder disease
*  History of small bowel surgery/resection impacting the terminal ileum that may disrupt the enterohepatic circulation.
*  Evidence, history, or suspicion of other liver diseases; PBC patients with AIH are not excluded
*  History of Liver transplantation
Show more

Participate in this trial

Are you interested in enrolling in this study? Learn more here.

I'm Interested In Participating

For Referring Providers

Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.

Contact the study coordinator

Jena Neuhaus
Enroll your patient